A multi-country clinical trial has shown that a structured, sustainable approach to infection prevention and treatment can save women’s lives, cutting severe maternal infections and deaths by about one-third (32%) compared to usual care. The maternal program of prevention and treatment (APT-Sepsis) was developed by researchers at the University of Liverpool, the World Health Organization (WHO) and the UN’s Special Program in Human Reproduction (HRP).

